Hansa Biopharma (previously known as Hansa Medical) is a biopharmaceutical company developing immunomodulating therapies. It offers an enzyme technology platform that helps to develop immunomodulatory treatments for rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer.